Copper-Induced Upregulation of MicroRNAs Directs the Suppression of Endothelial LRP1 in Alzheimer's Disease Model.
Alzheimer Disease
/ chemically induced
Animals
Brain
/ blood supply
Cell Survival
/ drug effects
Copper
/ toxicity
Disease Models, Animal
Endothelial Cells
/ drug effects
Female
Humans
Low Density Lipoprotein Receptor-Related Protein-1
/ antagonists & inhibitors
Male
Maze Learning
/ drug effects
Mice
Mice, Inbred C57BL
Mice, Transgenic
MicroRNAs
/ genetics
Microvessels
/ drug effects
Spatial Memory
/ drug effects
Transfection
Up-Regulation
J20 mice
amyloid-beta
cognition
mouse model
vasculature
Journal
Toxicological sciences : an official journal of the Society of Toxicology
ISSN: 1096-0929
Titre abrégé: Toxicol Sci
Pays: United States
ID NLM: 9805461
Informations de publication
Date de publication:
01 07 2019
01 07 2019
Historique:
pubmed:
30
3
2019
medline:
25
7
2020
entrez:
30
3
2019
Statut:
ppublish
Résumé
Chronic exposure to copper and its dyshomeostasis have been linked to accelerated cognitive decline and potentially increasing risk for Alzheimer's disease (AD). We and others have previously demonstrated that exposure to copper through drinking water significantly increased parenchymal amyloid-beta (Aβ) plaques and decreased endothelial low-density lipoprotein receptor-related protein 1 (LRP1) in mouse models of AD. In this study, we determined the underlying mechanisms that microRNA critically mediated the copper-induced loss of endothelial LRP1. In human primary microvascular endothelial cells (MVECs), microRNA-200b-3p, -200c-3p, and -205-5p were significantly elevated within the 24-h exposure to copper and returned to baseline after 48-h postexposure, which corresponded with the temporal change of LRP1 expression in these cells. Transient expression of synthetic microRNA-200b-3p, -200c-3p, or -205-5p on MVECs significantly decreased endothelial LRP1, and cotreatment of synthetic antagomirs effectively prevented the loss of LRP1 during copper exposure, collectively supporting the key regulatory role of these microRNAs in copper-induced loss of LRP1. In mice, a significant reduction of LRP1 in cortical vasculature was evident following 9 months exposure to 1.3 ppm copper in drinking water, although the levels of cortical microRNA-205-5p, -200b-3p, and -200c-3p were only marginally elevated. This, however, correlated with increased vascular accumulation of Aβ and impairment of spatial memory, indicating that copper exposure has the pivotal role in the vascular damage and development of cognitive decline.
Identifiants
pubmed: 30923833
pii: 5421824
doi: 10.1093/toxsci/kfz084
pmc: PMC6592190
doi:
Substances chimiques
LRP1 protein, human
0
Low Density Lipoprotein Receptor-Related Protein-1
0
MicroRNAs
0
Copper
789U1901C5
cupric chloride
S2QG84156O
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
144-156Subventions
Organisme : NIEHS NIH HHS
ID : R01 ES024331
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Clin Neurophysiol. 2010 Apr;121(4):502-7
pubmed: 20097602
J Clin Invest. 2000 Nov;106(9):1159-66
pubmed: 11067868
Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
pubmed: 18158296
J Alzheimers Dis. 2018;63(1):365-372
pubmed: 29578488
JAMA Neurol. 2017 Feb 1;74(2):207-215
pubmed: 27992627
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1412-21
pubmed: 24812324
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
Brain Res. 2014 Oct 2;1583:55-64
pubmed: 25152461
J Lipid Res. 2017 Jul;58(7):1267-1281
pubmed: 28381441
Obes Surg. 2011 Sep;21(9):1482-3; author reply 1484-5
pubmed: 21671052
J Neurosci. 2017 Apr 12;37(15):4023-4031
pubmed: 28275161
J Cereb Blood Flow Metab. 2007 May;27(5):909-18
pubmed: 17077814
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12849-54
pubmed: 17652175
Int J Alzheimers Dis. 2013;2013:623241
pubmed: 24228186
J Biol Chem. 2010 Jun 11;285(24):18344-51
pubmed: 20395292
Oncol Rep. 2016 Oct;36(4):1837-44
pubmed: 27574009
Am J Med Sci. 1986 Dec;292(6):344-9
pubmed: 3799705
Acta Neuropathol. 2006 Oct;112(4):405-15
pubmed: 16865397
Nutrients. 2015 Dec 02;7(12):10053-64
pubmed: 26633489
Ann Neurol. 2014 Apr;75(4):574-80
pubmed: 24623259
J Alzheimers Dis. 2011;23(2):239-48
pubmed: 20930297
Mol Neurobiol. 2014 Aug;50(1):97-106
pubmed: 24293102
Neurosci Lett. 2011 Jan 3;487(1):94-8
pubmed: 20934487
J Neurosci. 2015 Nov 4;35(44):14717-26
pubmed: 26538644
Am J Clin Nutr. 2008 Sep;88(3):826S-9S
pubmed: 18779302
Nat Neurosci. 2015 Jul;18(7):978-87
pubmed: 26005850
Mol Neurobiol. 2017 Dec;54(10):7736-7745
pubmed: 27844283
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14771-6
pubmed: 23959870
J Alzheimers Dis. 2015;49(3):755-66
pubmed: 26484928
Biochem Biophys Res Commun. 2009 Oct 16;388(2):400-5
pubmed: 19665999
J Gerontol A Biol Sci Med Sci. 1997 Mar;52(2):M117-25
pubmed: 9060980
Stroke. 2004 Nov;35(11 Suppl 1):2628-31
pubmed: 15459432
Free Radic Biol Med. 2009 Jan 1;46(1):95-104
pubmed: 18977292
Mol Cell Neurosci. 2016 Mar;71:13-24
pubmed: 26658803
Hum Mol Genet. 2010 Oct 15;19(20):3959-69
pubmed: 20660113
Toxicol Sci. 2018 Jul 1;164(1):250-263
pubmed: 29617964
Oncotarget. 2017 Mar 7;8(10):16122-16143
pubmed: 28179587
J Alzheimers Dis. 2014;39(2):253-9
pubmed: 24157723
J Struct Biol. 2006 Jul;155(1):30-7
pubmed: 16325427
Ann Neurol. 2012 Aug;72(2):269-77
pubmed: 22926857
Nat Commun. 2013;4:2932
pubmed: 24336108
J Trace Elem Med Biol. 2010 Jul;24(3):169-73
pubmed: 20569929
J Neurosci. 2013 Dec 4;33(49):19276-83
pubmed: 24305823
Food Chem. 2014 Dec 1;164:50-4
pubmed: 24996304
J Vasc Surg. 2017 Feb;65(2):509-520
pubmed: 26781079
Antioxid Redox Signal. 2010 Mar;12(3):327-36
pubmed: 19686046
J Neurochem. 2012 Nov;123(4):477-90
pubmed: 22906125
Front Genet. 2013 Feb 06;3:327
pubmed: 23390425
JAMA Neurol. 2014 Apr;71(4):505-8
pubmed: 24493463
Ann Neurol. 2015 Sep;78(3):439-53
pubmed: 26040676
Neurology. 2006 Jul 11;67(1):76-82
pubmed: 16832081
J Neuropathol Exp Neurol. 2010 Oct;69(10):1034-43
pubmed: 20838242
J Neurosurg. 2016 Jan;124(1):122-8
pubmed: 26230475
Lancet Neurol. 2010 Jan;9(1):119-28
pubmed: 20083042
Dement Geriatr Cogn Disord. 2017;44(1-2):25-34
pubmed: 28633142
Free Radic Biol Med. 2019 Apr;134:248-259
pubmed: 30660502
Toxicol Sci. 2018 Jun 1;163(2):338-345
pubmed: 29409005
Science. 2010 Dec 24;330(6012):1774
pubmed: 21148344
J Alzheimers Dis. 2014;42(4):1229-38
pubmed: 25024332
Theranostics. 2017 Jun 1;7(8):2186-2203
pubmed: 28740544
Arch Gen Psychiatry. 2006 Feb;63(2):168-74
pubmed: 16461860
Hum Mol Genet. 2013 Feb 1;22(3):608-20
pubmed: 23125283
J Neurosci. 2012 Nov 14;32(46):16458-65
pubmed: 23152628
Arch Neurol. 2006 Aug;63(8):1085-8
pubmed: 16908733
Alzheimers Dement (Amst). 2015 Dec 12;3:7-17
pubmed: 27239545
Curr Protoc Neurosci. 2014 Oct 08;69:8.31.1-17
pubmed: 25297693
Toxicol Sci. 2016 Jul;152(1):194-204
pubmed: 27122238
EMBO J. 2014 Aug 1;33(15):1667-80
pubmed: 25001178
Front Mol Neurosci. 2016 Dec 08;9:140
pubmed: 28008308
J Alzheimers Dis. 2012;30(4):981-4
pubmed: 22475798
J Clin Invest. 2016 Jan;126(1):123-36
pubmed: 26619118
J Alzheimers Dis. 2008 May;14(1):27-41
pubmed: 18525125